MGMT and glioblastoma: In a multivariate analysis accounting for gender, age, GBM transcriptomic subtypes, MGMT methylation status and treatment (chemoradiation vs radiation alone); M-H versus M-La or M-Lb independently predicted shorter survivals (p= 3.0E-3 and 2.7E-13, respectively; Supplementary Table 3).